In:
Journal of the National Comprehensive Cancer Network, Harborside Press, LLC, Vol. 17, No. 12 ( 2019-12), p. 1464-1472
Abstract:
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update, all of the systemic therapy regimens have been categorized using a new preference stratification system; certain regimens are now recommended as “preferred interventions,” whereas others are categorized as either “other recommended interventions” or “useful under certain circumstances.”
Type of Medium:
Online Resource
ISSN:
1540-1405
,
1540-1413
DOI:
10.6004/jnccn.2019.0059
Language:
Unknown
Publisher:
Harborside Press, LLC
Publication Date:
2019
Bookmarklink